Blood test breakthrough could end diagnostic confusion for bleeding disorders
NCT ID NCT07298733
Summary
This study aims to find a better way to tell apart two similar conditions that cause low platelets and bleeding risk: primary immune thrombocytopenia (ITP) and low platelets caused by lupus (SLE). Researchers will test blood samples from 300 adults to see if measuring levels of two specific proteins (IL-1β and IL-33) can act as a clear diagnostic signpost. The goal is to help doctors make the right diagnosis faster, so patients can get the most appropriate treatment sooner.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IMMUNE THROMBOCYTOPENIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.